CSCO is delighted to announce that the 2016 memo-inOncology SPECIAL ISSUE ESMO congress report is available to download from our home page in Chinese and English versions now! The issue summarises the latest findings in NSCLC to emerge from the congress, including updates from currently ongoing immunotherapy trials, a look at the encouraging results from trials testing targeted therapy for rare driver mutations, and how targeting angiogenesis can prolong life in patients with metastatic lung cancer-and lots more. The memo inOncology series is supported by an unrestricted educational grant from Boehringer Ingelheim. Check out the memo homepage for previous editions and more information at http://www.springermedizin.at/memo-inoncology/home/

Download in Chinese

Download in English